The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 29, 2016

Filed:

Feb. 13, 2014
Applicant:

The Johns Hopkins University, Baltimore, MD (US);

Inventors:

Chao-Wei Hwang, Ellicott City, MD (US);

Hala J. Tomey, Washington, DC (US);

Jon R. Resar, Stevenson, MD (US);

Robert C. Matteson, III, Ellicott City, MD (US);

George L. Coles, Jr., Baltimore, MD (US);

Jason J. Benkoski, Ellicott City, MD (US);

Morgana M. Trexler, Baltimore, MD (US);

Assignee:

The Johns Hopkins University, Baltimore, MD (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/52 (2006.01); A61F 2/82 (2013.01); A61K 9/00 (2006.01); A61L 31/16 (2006.01); A61M 31/00 (2006.01);
U.S. Cl.
CPC ...
A61F 2/82 (2013.01); A61K 9/0012 (2013.01); A61K 9/0024 (2013.01); A61K 9/0097 (2013.01); A61L 31/16 (2013.01); A61M 31/002 (2013.01); A61F 2240/001 (2013.01); A61F 2250/0068 (2013.01); A61F 2250/0071 (2013.01); A61L 2300/42 (2013.01); A61L 2300/602 (2013.01); Y10T 29/49826 (2015.01);
Abstract

Implantable pressure-actuated systems to deliver a drug and/or other substance in response to a pressure difference between a system cavity and an exterior environment, and methods of fabrication and use. A pressure-rupturable membrane diaphragm may be tuned to rupture at a desired rupture threshold, rupture site, with a desired rupture pattern, and/or within a desired rupture time. Tuning may include material selection, thickness control, surface patterning, substrate support patterning. The cavity may be pressurized above or evacuated below the rupture threshold, and a diaphragm-protective layer may be provided to prevent premature rupture in an ambient environment and to dissipate within an implant environment. A drug delivery system may be implemented within a stent to release a substance upon a decrease in blood pressure. The cavity may include a thrombolytic drug to or other substance to treat a blood clot.


Find Patent Forward Citations

Loading…